2009 Midyear Clinical Meeting
Click here to go to the previous page
Optimizing Patient Comfort with Safe and Effective Sedation
Track:
Educational Sessions (CE)
Program Code: 231-L04
Date: Tuesday, December 8, 2009
Time: 9:00 AM to 11:00 AM EST
Location:
Lido 3104
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Lois Parker,
BS, RPh, Senior Attending Pharmacist, PICU; and Pediatric Pharmacy Team Lead,
Massachusetts General Hospital
Lois Finstein Parker is currently a Senior Attending Pharmacist at Msssachusetts General Hospital at Boston, where she practices in the pediatric ICU. In June 2009, she was appointed Pediatric Pharmacy Team Lead. She received her B.S. in Pharmacy from the University of Connecticut School of Pharmacy. She is the administrator of the MGH Department of Pharmacy's ACPE-accredited continuing pharmacy education program, and for the past three years, has been a member of the Educational Steering Committee through ASHP's Section of Inpatient Care Practitioners.
|
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Brian Cummings,
MD, Attending Physician, Pediatric Critical Care,
MassGeneral Hospital for Children
Dr. Cummings received his undergraduate degree in Biology at Boston College
before earning his medical degree at the University of Connecticut. He
completed his residency in Pediatrics and a fellowship in Pediatric
Critical Care at MassGeneral Hospital for Children in Boston. He also
completed a clinical fellowship in medical ethics at Harvard Medical
School. He is currently an Assistant Professor of Pediatrics in Pediatric
Critical Care at MassGeneral Hospital for Children, as well as an
Instructor in Pediatrics at Harvard Medical School. His clinical interests
are in sedation and pain management in the ICU and clinical ethics in
pediatrics, particularly in end of life.
|
Dr. Erstad is currently a full Professor and Assistant Department Head in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. He is also a Center Investigator for the Center for Health Outcomes and Pharmacoeconomics Research and a co-director for the Arizona Clinical Research Training Program. His clinical responsibilities are performed at University Medical Center. Dr. Erstads research interests pertain to critical care medicine with an emphasis on patient safety and related outcomes research - he has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad was on the Board of Directors of the American Society of Health-System Pharmacists and has served on numerous committees and task forces for various organizations including AHRQ, USP, ISPOR, the Society of Critical Care Medicine and the American College of Chest Physicians. Dr. Erstad was the first pharmacist to receive the Society of Critical Care Medicines Shubin-Weil Master Clinician/Teacher Excellence in Bedside Teaching Award.
|
Lois Parker,
BS, RPh, Senior Attending Pharmacist, PICU; and Pediatric Pharmacy Team Lead,
Massachusetts General Hospital
Lois Finstein Parker is currently a Senior Attending Pharmacist at Msssachusetts General Hospital at Boston, where she practices in the pediatric ICU. In June 2009, she was appointed Pediatric Pharmacy Team Lead. She received her B.S. in Pharmacy from the University of Connecticut School of Pharmacy. She is the administrator of the MGH Department of Pharmacy's ACPE-accredited continuing pharmacy education program, and for the past three years, has been a member of the Educational Steering Committee through ASHP's Section of Inpatient Care Practitioners.
|
Description
Planned in cooperation with the ASHP Section of Inpatient Care Practitioners
ACPE Activity #204-000-09-231-L04P
2.0 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: Lois F. Parker, BS, RPh, Senior Attending Pharmacist, PICU; and Pediatric Pharmacy Team Lead, Massachusetts General Hospital, Boston
9:00 a.m. - 9:05 a.m.
Announcements
9:05 a.m. - 9:15 a.m.
The Levels of Sedation
Brian L. Erstad, PharmD, FASHP, Professor, The University of Arizona, Tucson
9:15 a.m. - 9:25 a.m.
Comparison of the Agents Commonly Used for Sedation
Brian Erstad
9:25 a.m. - 9:40 a.m.
Existing Sedation Guidelines and Their Limitations
Brian Erstad
9:40 a.m. - 9:55 a.m.
A Case-Based Approach to Design a Sedation Plan and Select an Appropriate Agent for Several Clinical Scenarios, including Procedural, ED, and Adult ICU
Brian Erstad
9:55 a.m. - 10:10 a.m.
Considerations Involved in Sedation for Pediatric Patients in Both General Care Units and ICUs
Brian M. Cummings, MD, Attending Physician, Pediatric Critical Care, MassGeneral Hospital for Children, Boston, MA
10:10 a.m. - 10:25 a.m.
Alternate Routes of Administration for Sedatives, including Intransal and Oral
Brian Cummings
10:25 a.m. - 10:40 a.m.
Issues Associated with Providing Palliative Sedation
Brian Cummings
10:40 a.m. - 10:55 a.m.
Case-Based Approach to Design a Sedation Plan and Select an Appropriate Agent for Several Clinical Scenarios Utilizing Pediatric and Palliative Care Patients
Brian Cummings
10:55 a.m. - 11:00 a.m.
Questions, Answers, and Discussion
Learning Objectives:
- Compare and contrast the agents commonly used for sedation.
- Describe a sedation plan for a specific patient.
- Explain some of the special considerations involved in sedation, including palliative sedation, ICU sedation, and pediatric sedation.
- Identify clinical indications in which sedation may be indicated, including interventional procedures, line placement, bone marrow biopsy, sutures, fracture reduction, and lumbar puncture.